🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nataša Obermajer

Palo Alto University

ORCID: 0000-0002-0838-7508

Also affiliated with BioQ Pharma (United States)

Immunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs”.

NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0061
N/A
0.292DataRank · unranked
6 citations

Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura, Cindy Sander +11 more

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells

Research Square(2023)10.21203/rs.3.rs-3399211/v1
N/A
0DataRank · unranked
1 citations

Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M. Bonura +9 more

Data from PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment

(2023)10.1158/0008-5472.c.6503124.v1
N/A
0DataRank · unranked
0 citations

Ravikumar Muthuswamy, Kunle Odunsi, Robert P. Edwards, Paweł Kaliński, Nataša Obermajer